Wernstedt, P <br/><br/>
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.  [electronic resource] 

 -  Bone marrow transplantation  Dec 2002 
 - 971-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703760  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amsacrine--administration & dosage<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Benzamides<br/>Betamethasone--administration & dosage<br/>Biomarkers, Tumor--genetics<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Drug Resistance, Neoplasm<br/>Enzyme Inhibitors--therapeutic use<br/>Etoposide--administration & dosage<br/>Female<br/>Fusion Proteins, bcr-abl--genetics<br/>Graft vs Host Disease--drug therapy<br/>Humans<br/>Imatinib Mesylate<br/>Immunosuppressive Agents--therapeutic use<br/>Mitoxantrone--administration & dosage<br/>Neoplasm, Residual<br/>Peripheral Blood Stem Cell Transplantation<br/>Piperazines--therapeutic use<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Pyrimidines--therapeutic use<br/>Remission Induction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transplantation, Homologous<br/>Vincristine--administration & dosage